Epigenetic Inactivation and Clinical Significance of Tumor Suppressor Gene RASSF1A in Hepatocellular Carcinoma

周晓俊,薛万江,秦磊,钱海鑫

DOI: https://doi.org/10.3969/j.issn.0253-3685.2007.01.010

2007-01-01

Abstract:Objective To study the expression of tumor suppressor gene RASSF1A and the status of aberrant promoter hypermethylation in hepatocellular carcinoma(HCC),which induces the epigenetic inactivation of tumor suppressor gene,RASSF1A,and analyzing the correlation between aberrant DNA methylation and clinical relative factors in HCC.Methods RT-PCR and MS-PCR strategies,combined with bisulfite DNA sequencing and TaqⅠ digestion,were used for analyzing the status of aberrant promoter methylation of RASSF1A in twenty-four primary HCC samples and adjacent noncanerous tissues,and four HCC cell lines.To assess reactivation of RASSF1A expression,three HCC cell lines were treated by demethylating agent 5′-aza-2′-deoxycytideing(5′-Aza-CdR). Results RASSF1A mRNA was not detected in 66.7% of HCC.Three of four HCC cell lines missed the expression of RASSF1A.By contrast,RASSF1A was expressed in all normal liver and normal liver cell line(L02).MS-PCR analysis demonstrated that RASSF1A promoter region hypermethylation was found in 83.3% of HCC samples,four cell lines were all detected promoter methylation.No methylation was detected in normal liver and normal cell lines(L02).Aberrant promoter hypermethylation of RASSF1A was correlated with hepatocirrhosis,HBsAg,tumor differentiation grade and metastasis, but not with tumor stage and histological type.Three RASSF1A-nonexpressing cell lines were all re-expressed after treated with 5′-Aza-CdR.Conclusion RASSF1A inactivation might be caused by epigenetic and genetic mechanisms in HCC.Testing for RASSF1A methylation should be useful in early detection and diagosis of HCC and could be utilized as a molecular marker to estimate the prognosis of HCC.